anti-SARS, Nucleocapsid Protein antibody product blog
Tags: Antibody; Monoclonal Antibody; SARS, Nucleocapsid Protein; anti-SARS, Nucleocapsid Protein antibody;
The SARS, Nucleocapsid Protein n/a (Catalog #MBS632433) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s SARS, Nucleocapsid Protein can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB).Suitable for use in Western Blot.
Dilution: Western Blot: 1:500-1:1000. Researchers should empirically determine the suitability of the SARS, Nucleocapsid Protein n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the SARS, Nucleocapsid Protein (Severe Acute Respiratory Syndrome) with the following immunoassay(s):
Western Blot (WB) (Western blot analysis of SARS Nucleocapsid in (A) transfected mouse melanoma cell lysate and (B) untransfected cell lysate using IMG-655 at 1:1000.)
It has recently been shown that SARS is caused by a human coronavirus. Human coronaviruses are the major cause of upper respiratory tract illness in humans, such as the common cold. Coronaviruses are positive-stranded RNA viruses, featuring the largest viral RNA genomes known to date (27-31 kb). The first step in coronavirus infection is binding of the viral spike protein, a 139-kD protein, to certain receptors on host cells. The spike protein is the main surface antigen of the coronavirus. The most prominent protein in the culture supernatants infected with SARS virus is a 46kD nucleocapsid protein.
Immunogen: Full-length recombinant SARS nucleocapsid protein (Genbank accession no. NP_828858). The specific epitope has not been determined. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing SARS, Nucleocapsid Protein are readily searchable from our website. Different antibodies against the same target such as SARS, Nucleocapsid Protein may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.